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Introduction and Aims: Kidney transplant recipients are at increased risk of
cardiovascular disease compared with the general population. In CKD, accelerated
calcification contributes to arterial stiffness andmortality. A blood test for calcification
propensity was recently developed by measuring the maturation time (T50) of calciprotein
particles in serum, with a lower T50 corresponding to a higher calcification propensity. The
prognostic implication of T50 in kidney transplant recipients is not known.
Methods:Wemeasured T50 in biobanked blood obtained 10 weeks after transplantation
during two eras, 2000-2003 and 2009-2012. Survival was assessed in Cox regression
models, adjusting for age, gender and clinical correlates of T50 including era, diabetes
including post-transplant diabetes, first kidney recipient, deceased donor kidney, rejection,
cytomegalovirus infection, eGFR, phosphate, prednisolone dose ≥12.5 mg and highest
quartile of calcineurin inhibitor trough levels (TAC >8.5 or CsA >220 ng/mL). Although
T50 was lower during the first era, there was no interaction between era and T50 regarding
survival and the cohorts were combined in the survival analyses. Patients with missing
values (1%) were excluded from the multivariable model. Due to non-linearity, T50 was
modeled as quartiles with median levels at 111, 165, 216 and 287 minutes, respectively.
Results:Of 1886 eligible adult kidney or kidney-pancreas recipients during the two eras,
1435 (76%) had T50 measured. Hospital staff shortage excluded 161 patients and 290 were
transferred to other hospitals before the investigation in week 10.
The cohort was primarily Caucasian with mean age 52 ± 14 years, eGFR 57 ± 19 ml/min/
1.73m2, male 66%, diabetes 29.1% including 9.3% post-transplant diabetes, simultaneous
pancreas transplant 6% and T50 196 ± 72 minutes.
Median (25th, 75th percentile) follow-up was 5.1 (3.5, 11.6) years. All-cause and
cardiovascular mortality occurred in 283 and 104 patients, respectively. As shown in the
table, lower quartiles of T50 were strongly associated with both endpoints.
SaO031 Table 1: Survival models
Age- and gender adjusted
HR (95% CI), p-value
Multivariable
HR (95% CI), p-value
All-cause mortality
Q1 2.12 (1.43-3.14), <0.001 1.80 (1.13-2.87), 0.01
Q2 2.07 (1.39-3.06), <0.001 1.93 (1.28-2.92), 0.002
Q3 1.51 (0.99-2.30), 0.06 1.38 (0.90-2.12), 0.14
Q4 Reference Reference
Cardiovascular mortality
Q1 5.02 (1.96-12.87), 0.001 4.18 (1.49-11.76), 0.01
Q2 6.31 (2.49-15.98), <0.001 5.66 (2.18-14.73), <0.001
Q3 4.24 (1.62-11.08), 0.003 3.73 (1.41-9.86), 0.01
Q4 Reference Reference
Q, quartile of T50.
Conclusions: Serum calcification propensity T50 is strongly associated with all-cause
and cardiovascular mortality in kidney transplant recipients.
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